Akaike T (1982) Periodic bursting activities of locus coerulleus neurons in the rat.
Brain Res 239:629 – 633.
Arnsten AF (2001) Modulation of prefrontal cortical-striatal circuits: relevance to
therapeutic treatments for Tourette syndrome and attention-deficit hyperactivity
disorder. Adv Neurol 85:333–341.
Arnsten AF and Dudley AG (2005) Methylphenidate improves prefrontal cortical
cognitive function through alpha2 adrenoceptor and dopamine D1 receptor ac- tions: relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.
Behav Brain Funct 1:2.
Arnsten AF and Li BM (2005) Neurobiology of executive functions: catecholamine
influences on prefrontal cortical functions. Biol Psychiatry 57:1377–1384.
Aston-Jones G and Bloom FE (1981a) Activity of norepinephrine-containing locus
coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking
cycle. J Neurosci 1:876 – 886.
Aston-Jones G and Bloom FE (1981b) Nonrepinephrine-containing locus coeruleus
neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J Neurosci 1:887–900.
Berridge CW (2001) Arousal- and attention-related actions of the locus coeruleusnoradrenergic system: potential target in the therapeutic actions of amphetaminelike stimulants, in Stimulant Drugs and ADHD: Basic and Clinical Neuroscience
(Solanto MV, Arnsten AFT, and Castellanos FX eds) pp 158 –184, Oxford University Press, New York.
Berridge CW and Abercrombie ED (1999) Relationship between locus coeruleus
discharge rates and rates of norepinephrine release within neocortex as assessed
by in vivo microdialysis. Neuroscience 93:1263–1270.
Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AFT, Kelley AE, Schmeichel
B, Hamilton CM, and Spencer RC (2006) Methylphenidate preferentially increases
catecholamine neurotransmission within the prefrontal cortex at low doses that
enhance cognitive function. Biol Psychiatry, in press.
Berridge CW and Foote SL (1991) Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci 11:3135–3145.
Berridge CW and Morris MF (2000) Amphetamine-induced activation of forebrain
EEG is prevented by noradrenergic beta-receptor blockade in the halothaneanesthetized rat. Psychopharmacology (Berl) 148:307–313.
Berridge CW, Page ME, Valentino RJ, and Foote SL (1993) Effects of locus coeruleus
inactivation on electroencephalographic activity in neocortex and hippocampus.
Neuroscience 55:381–393.
Berridge CW and Waterhouse BD (2003) The locus coeruleus-noradrenergic system:
modulation of behavioral state and state-dependent cognitive processes. Brain Res
Brain Res Rev 42:33– 84.
Biederman J and Spencer T (1999) Attention-deficit/hyperactivity disorder (ADHD)
as a noradrenergic disorder. Biol Psychiatry 46:1234 –1242.
Clayton EC, Rajkowski J, Cohen JD, and Aston-Jones G (2004) Phasic activation of
monkey locus ceruleus neurons by simple decisions in a forced-choice task. J Neurosci 24:9914 –9920.
Devilbiss DM and Berridge CW (2003) Effects of low, clinically-relevant doses of
methylphenidate on tonic and phasic locus coeruleus neuronal discharge, in An- nual Meeting of the Society for Neuroscience; 2003 Nov 7–12; Washington, DC.
Program No. 324.1, Society for Neuroscience, Washington, DC.
Devilbiss DM and Waterhouse BD (2004) The effects of tonic locus ceruleus output on
sensory-evoked responses of ventral posterior medial thalamic and barrel field
cortical neurons in the awake rat. J Neurosci 24:10773–10785.
Foote SL, Aston-Jones G, and Bloom FE (1980) Impulse activity of locus coeruleus
neurons in awake rats and monkeys is a function of sensory stimulation and
arousal. Proc Natl Acad Sci USA 77:3033–3037.
Graham AW and Aghajanian GK (1971) Effects of amphetamine on single cell
activity in a catecholamine nucleus, the locus coeruleus. Nature (Lond) 234:100 –
102.
Greenhill LL (2001) Clinical effects of stimulant medication in ADHD, in Stimulant
Drugs and ADHD: Basic and Clinical Neuroscience (Solanto MV, Arnsten AFT,
and Castellanos FX eds) pp 31–71, Oxford University Press, New York.
Ishimatsu M, Kidani Y, Tsuda A, and Akasu T (2002) Effects of methylphenidate on
the membrane potential and current in neurons of the rat locus coeruleus. J Neurophysiol 87:1206 –1212.
Kuczenski R and Segal DS (1994) Neurochemistry of amphetamine, in Amphetamine
and Its Analogues: Psychopharmacology, Toxicology and Abuse (Cho AK and Segal
DS eds) pp 81–113, Academic Press, San Diego.
Kuczenski R and Segal DS (2001) Locomotor effects of acute and repeated threshold
doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 296:876 – 883.
Kuczenski R and Segal DS (2002) Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22:7264 –7271.
Lacroix D and Ferron A (1988) Electrophysiological effects of methylphenidate on the
coeruleo- cortical noradrenergic system in the rat. Eur J Pharmacol 149:277–285.
McGaughy J and Sarter M (1995) Behavioral vigilance in rats: task validation and
effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology (Berl) 117:340 –357.
Mehta MA, Sahakian BJ, and Robbins TW (2001) Comparative psychopharmacology
of methylphenidate and related drugs in human volunteers, patients with ADHD,
and experimental animals, in Stimulant Drugs and ADHD: Basic and Clinical
Neuroscience (Solanto MV, Arnsten A.FT, and Castellanos FX eds) pp 303–331,
Oxford University Press, New York.
Page ME and Abercrombie ED (1999) Discrete local application of corticotropinreleasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus. Synapse 33:304 –313.
Rajkowski J, Kubiak P, and Aston-Jones G (1994) Locus coeruleus activity in monkey: phasic and tonic changes are associated with altered vigilance. Brain Res Bull
35:607– 616.
Rapoport JL, Buchsbaum MS, Weingartner H, Zahn TP, Ludlow C, and Mikkelsen
